
|Articles|July 8, 2016
HIV Drug Cost Increase Controversy Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/hiv-drug-cost-increase-controversy-highlights-spec" target="_blank">View the story "HIV Drug Cost Increase Controversy Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma
4
Environmental Factors Could Influence Type 1 Diabetes Risk in Children Through Epigenetic Changes
5












































































































































































































